Last reviewed 2026-04-20 · How we verify

Iodine, Compd. With 1-Ethenyl-2-Pyrrolidinone Homopolymer (kt-136)

Iodine, Compd. With 1-Ethenyl-2-Pyrrolidinone Homopolymer (generic name: kt-136) is a drug. It is currently in unknown development.

Iodine, Compd. With 1-Ethenyl-2-Pyrrolidinone Homopolymer (kt-136) is thought to work by releasing iodine ions, which may have antimicrobial or antifungal properties.

Iodine, Compd. With 1-Ethenyl-2-Pyrrolidinone Homopolymer (kt-136) is a small molecule compound with unknown target and drug class. Its commercial status is unclear, and it has not been approved by the FDA for any indications. The compound is a polymer-based iodine complex, and its mechanism of action is not well-documented. Further research is needed to understand its potential therapeutic applications and safety profile.

At a glance

Mechanism of action

Imagine your body as a fortress, and the iodine ions are like special soldiers that help fight off invading germs and fungi. This compound is designed to slowly release these soldiers, which can then target and destroy the invading microorganisms. However, more research is needed to fully understand how it works and its potential effects on the body.

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

• Iodine, Compd. With 1-Ethenyl-2-Pyrrolidinone Homopolymer CI brief — competitive landscape report
• Iodine, Compd. With 1-Ethenyl-2-Pyrrolidinone Homopolymer updates RSS · CI watch RSS
• portfolio CI

Frequently asked questions about Iodine, Compd. With 1-Ethenyl-2-Pyrrolidinone Homopolymer

Related

• Manufacturer: — full pipeline
• Therapeutic area: All drugs in Infectious Disease

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing